<DOC>
	<DOCNO>NCT00768716</DOCNO>
	<brief_summary>Although acetaminophen commonly use nonprescription drug USA , little know regard influence gene race/ethnicity acetaminophen disposition . The investigator long-term goal understand cause difference acetaminophen disposition people result genetic variation ethnicity may predispose individual high risk acetaminophen hepatotoxicity . The aim particular study measure rate elimination acetaminophen via 3 main pathway ( glucuronidation , sulfation oxidation ) self-identified White-Americans ( n=100 ) African-Americans ( n=100 ) . These rate correlate select genetic polymorphism gene encode enzymes involve acetaminophen metabolism . Two main hypothesis test : 1 . African-Americans eliminate acetaminophen rapidly glucuronidation White-Americans . 2 . Elimination via glucuronidation , sulfation , oxidation subject significantly correlate presence polymorphism UGT1A6 , SULT1A1 , CYP2E1 gene , respectively .</brief_summary>
	<brief_title>Effect Race/Ethnicity Genes Acetaminophen Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>selfdeclared white/Caucasian selfdeclared AfricanAmerican active ambulatory evidence medical disease alcohol use 3 drink per day HIV hepatitis ( B C ) infection isoniazid disulfiram phenobarbital phenytoin carbamazepine rifampicin valproic acid probenecid St. John 's Wort</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>